Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human PCDH20 ELISA Kit (AC2588)
Cat.#: ASET-1177
Specifications
Description Human PCDH20 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human PCDH20 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.57 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 125-2000 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1692 Human LECT2 ELISA Kit (AC3103) Quantitative inquiry ASET-1277 Rat BACE2 ELISA Kit (AC2688) Quantitative inquiry ASET-1254 Human SHP2 ELISA Kit (AC2665) Quantitative inquiry ASET-1975 Human SOX6 ELISA Kit (AC3386) Quantitative inquiry ASET-1377 Rat Adiponectin ELISA Kit (AC2788) Quantitative inquiry ASET-1774 Bovine Ghrelin ELISA Kit (AC3185) Quantitative inquiry ASET-2537 Human Neurofilament Heavy Polypeptide ELISA Kit (AC3948) Quantitative inquiry ASET-1620 Human SOX2 ELISA Kit (AC3031) Quantitative inquiry ASET-1670 Human Histidine Decarboxylase ELISA Kit (AC3081) Quantitative inquiry ASET-1323 Rat Glutamine Synthetase ELISA Kit (AC2734) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket